Other Publication
News

FDA approves first generic tamsulosin to treat Enlarged Prostate Gland

Maryland
03 Mar, 2010

The U.S. Food and Drug Administration approved the first generic version of Flomax Capsules 0.4 mg to treat Benign Prostatic Hyperplasia (BPH), a condition in which an enlarged prostate gland causes problems with urination.

The most common symptoms of BPH include a weak stream during urination, urgency, leaking or dribbling, as well as more frequent urination, especially at night.

BPH is common among older men. According to the National Institutes of Health, it rarely causes symptoms before age 40, but more than half of men in their 60s and as many as 90 percent of men older than 70 have BPH symptoms.

The prescribing information and safety warnings for the generic version of tamsulosin are the same as those for Flomax Capsules. IMPAX Laboratories Inc. of Haywood, Calif. Information about the marketing manufactures generic tamsulosin capsules and availability of this generic drug can be obtained from the manufacturer.

Source: FDA

Previous News


 
Web Counter: